A / A / A
Date de publication
Joan
Amondi

Joan Amondi graduated in Literature (Moï University, Eldoret, Kenya). She has worked for MSF-Crash as an interpreter, a translator and a research assistant. 

Jean-Hervé Bradol
Jean-Hervé
Bradol

Medical doctor, specialized in tropical medicine, emergency medicine and epidemiology. In 1989 he went on mission with Médecins sans Frontières for the first time, and undertook long-term missions in Uganda, Somalia and Thailand. He returned to the Paris headquarters in 1994 as a programs director. Between 1996 and 1998, he served as the director of communications, and later as director of operations until May 2000 when he was elected president of the French section of Médecins sans Frontières. He was re-elected in May 2003 and in May 2006. From 2000 to 2008, he was a member of the International Council of MSF and a member of the Board of MSF USA. He is the co-editor of "Medical innovations in humanitarian situations" (MSF, 2009) and Humanitarian Aid, Genocide and Mass Killings: Médecins Sans Frontiéres, The Rwandan Experience, 1982–97 (Manchester University Press, 2017).

Elisabeth
Szumilin

Medical Doctor, HIV Specialist at Médecins Sans Frontières

BLUSTEIN, P. 2001, “Getting 0ut in Front on Trade: New U.S. Representative Adds ‘Values’ to His Globalization Plan”, The Washington Post, March 13.

BOULET, P., G. VELASQUEZ. 1999. Globalisation and access to drugs. Perspectives on the WTO TRIPS agreement. Geneva: World Health Organization.

CAMPAIGN FOR ACCESS TO ESSENTIAL MEDICINES, MÉDECINS SANS FRONTIÈRES (MSF). 2001. Accessing ARVs: untangling the web of price reductions for developing countries. Geneva: Campaign for Access to Essential Medicines, Médecins Sans Frontières.

CAMPAIGN FOR ACCESS TO ESSENTIAL MEDICINES, MÉDECINS SANS FRONTIÈRES. 2008. Untangling the Web of Antiretroviral Price Reductions, 11th edition. Geneva: Campaign for Access to Essential Medicines, Médecins Sans Frontières.

FERRADINI, L., A. JEANNIN, L. PINOGES, J. IZOPET, D. ODHIAMBO, L. MANKHAMBO, G. KARUNGI, E. SZUMILIN, S. BALANDINE, G. FEDIDA, M.P CARRIERI, B. SPIRE, N. FORD, J.M. TASSIE, P.J. GUERIN, C. BRASHER. 2006. “Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.” The Lancet. 367(9519): 1335–1342.

GRMEK, M., R. MAULITZ (TRANSLATOR), J. DUFFIN (TRANSLATOR). 1990. History of AIDS: Emergence and Origin of a Modern Pandemic. Princeton: Princeton University Press.

KASPER, T., D. COETZEE, F. LOUIS, A. BOULLE, K. HILDERBRAND. 2003. “Demystifying antiretroviral therapy in resource-poor settings,” Essential Drugs Monitor 32: 20–21.

MÉDECINS SANS FRONTIÈRES. 2008. Maputo statement. A renewed vision for MSF on HIV/AIDS from the field. Maputo, Mozambique.

WORLD HEALTH ORGANIZATIONS (WHO), JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (UNAIDS), UNITED NATIONS CHILDREN’S FUND (UNICEF). 2007. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector.” Geneva: World Health Organization.

PEREZ-CASAS, C. 2000. HIV/AIDS Medicines Pricing Report, Setting objectives: is there a political will? Geneva: Médecins Sans Frontières.

‘T HOEN, E. F. M. 2009. The Global Politics of Pharmaceutical Monopoly Power. Drug patents, access, innovation and the application of the WTO Doha Declaration on TRIPS and Public Health. Diemen, The Netherlands: AMB.